Phase II study of PSC 833 (PSC) and vad chemotherapy in patients with VAD-refractory multiple myeloma (MM) Meeting Abstract
| Authors: | Case, D. C.; Jain, V.; Stiff, P.; Jansen, J.; Stewart, A. K.; Shurafa, M.; Hussein, M.; Heffner, L. T.; Irwin, D.; Greipp, P.; Dalton, W.; Friedenberg, W.; Gucalp, R.; Anderson, K.; Catlett, J.; Lake, D.; Pincus, S.; Kerr, R.; Shustik, C.; Archinal-Mattheis, A. A.; Tarassoff, P.; Litchman, M. |
| Abstract Title: | Phase II study of PSC 833 (PSC) and vad chemotherapy in patients with VAD-refractory multiple myeloma (MM) |
| Meeting Title: | 40th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 92 |
| Issue: | 10 Suppl. 1 Pt. 1 |
| Meeting Dates: | 1998 Dec 4-8 |
| Meeting Location: | Miami Beach, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 1998-11-01 |
| Start Page: | 105a |
| Language: | English |
| ACCESSION: | WOS:000077121300424 |
| PROVIDER: | wos |
| PUBMED: | 9835841 |
| Notes: | Meeting Abstract: 427 -- Source: Wos |
Citation Impact
Related MSK Work